Sunday, 29 January 2012
  • Newletters
  • RSS
  • Subscribe
  • Twitter
  • Login
    • Move
    • Close

    Forgot your password? Forgot your username?
  • Register

Subscribe to Alerts!

Receive Terms and Conditions
  • Home
  • Articles
    • Our Articles
    • Article List
    • Breaking News
  • Blogs
  • Calendar
  • Quotes
  • Forum
  • Resources
    • Technical Analysis
    • Market Strategies
    • Bloomberg TV
    • Links
    • Polls
  • About Us

Adeona's reaZin, A Better Preventative than Cure?

Chemistfrog | Friday, 1 July 2011

Adeona Pharmaceuticals (AMEX: AEN) and its reaZin® prescription medical food for the management of Alzheimer’s disease and mild cognitive impairment has finally come full circle. After some promising interim data in 2010, the final data was presented at the 63rd Annual Meeting of the American Academy of Neurology on April 14, 2011 in Honolulu, Hawaii. The data indicated that the clinical study met the primary outcome of increasing serum zinc and decreasing serum free copper. Per the presentation, secondary outcomes of mental status as measured by three standardized cognitive tests all favored the treatment ...

READ MORE
  • Adeona's reaZin, A Better Preventative than Cure?

Recent News »

  • Adeona's reaZin, A Better Preventative than Cure?

  • L&L Energy, Inc. generated EPS Growth of 158.49% for current year – NASDAQ:LLEN

  • Synthesis Energy Systems, Inc. presenting marvelous Yearly & half yearly performance - NASDAQ:SYMX

  • Assured Guaranty Ltd. marvelous earnings per share growth at 286.89% for current year – AGO

  • Seagate Technology PLC having EPS Current Year Growth of 149.04% - NASDAQ:STX

  • Bed Bath & Beyond Inc. presenting Positive Distance From SMA20, SMA50 & SMA200 - NASDAQ:BBBY

  • Elan Corporation, plc (ADR) EPS Growth for next year hanged about 157.10% - NYSE:ELN

  • KB Home Enjoys Business with Optimum Debt to Equity Rate - NYSE:KBH

  • Stocks
  • Blog
  • Market Data
Loading
Chart
o Antigenics 2.79 ▲0.03 (1.09%)
o Biodel 0.58 ▼0.025 (-4.10%)
o Catalyst Pharmaceutical 1.11 ▼0.04 (-3.48%)
o Delcath Systems 3.85 ▲0.04 (1.05%)
NASDAQ:AGEN

Antigenics

Company ID [NASDAQ:AGEN] Last trade:2.79 Trade time:3:59PM EST Value change:▲0.03 (1.09%)
NASDAQ:BIOD

Biodel

Company ID [NASDAQ:BIOD] Last trade:0.58 Trade time:3:59PM EST Value change:▼0.025 (-4.10%)
NASDAQ:CPRX

Catalyst Pharmaceutical

Company ID [NASDAQ:CPRX] Last trade:1.11 Trade time:3:59PM EST Value change:▼0.04 (-3.48%)
NASDAQ:DCTH

Delcath Systems

Company ID [NASDAQ:DCTH] Last trade:3.85 Trade time:3:59PM EST Value change:▲0.04 (1.05%)
Japan's Eisai Drug Failure Presents Opportunity for Cytosorbents Corp
1 comment(s)
posted by Stephen Ramey on Tuesday, 25 January 2011


Read More
TTII Breakout Confirmed and Possible News Coming Soon?
0 comment(s)
posted by Stephen Ramey on Tuesday, 04 January 2011


Read More
Gener8xion Investors Patiently Await Business Update
0 comment(s)
posted by Stephen Ramey on Monday, 03 January 2011


Read More
Blast Applications Consolidating for Liftoff?
0 comment(s)
posted by Stephen Ramey on Tuesday, 21 December 2010


Read More
Cascade Technologies - At Support and Good Entry Point?
0 comment(s)
posted by Stephen Ramey on Thursday, 09 December 2010


Read More
Joomla Templates and Joomla Extensions by JoomlaVision.Com
  • US
  • ASIA
  • EU
0.000.00
NASDAQ2,816.55 +11.27 +0.40%
S&P1,316.33 -2.10 -0.16%
Treasury3.06 -0.03 -0.84%
Biodel0.59 -0.03 -4.10%
NIKKEI8,841.22 -8.25 -0.09%
FTSE1,522.66 +5.85 +0.39%
Composite3,986.41 +2.98 +0.07%
ALL4,348.50 +19.40 +0.45%
HANG20,501.67 +62.53 +0.31%
ATX 2,127.00 -12.20 -0.57%
EURONEXT2,237.59 -14.44 -0.64%
CAC3,318.76 -44.47 -1.32%
DAX 6,511.98 -27.87 -0.43%

Company Profiles

Elan Corporation, plc (ADR) EPS Growth for next year hanged about 157.10% - NYSE:ELN

Companies Profiles

Elan Corporation, plc (ADR) (NYSE:ELN) recently traded higher than its average volume.  ELN was opened at $7.15 increased +0.44 points or +6.15%. ELN transacted...

Read more
  • Advanced Battery Technologies, Inc. generated Return on Assets of 19.06% with no Debt in most recent

  • OFIRMEV’s Europe Track Record, A Good Omen for US Market, Cadence Pharmaceuticals (CADX)

  • Why Linjeta Could Revolutionize Diabetes Care, Biodel (NASDAQ: BIOD)

More in: Companies Profiles

Research

Adeona's reaZin, A Better Preventative than Cure?

Research

Adeona Pharmaceuticals (AMEX: AEN) and its reaZin® prescription medical food for the management of Alzheimer’s disease and mild cognitive impairment has fi...

Read more
  • FDA Panel Votes in Favor of Orexigen's Contrave (OREX)

  • Biodel's Stock Plunges Heavy as Company Receives CRL for Linjeta (BIOD)

  • Clarity on Linjeta from FDA May Give Shares a Boost (BIOD)

More in: Research

Opinion

Health-Care Bill And Its Effect On The Stock Market

News image

Opinions

With the passing of the health-care bill on Sunday, March 22, 2010, it marks a step of a new revolution in the American system that has endured for the past 100...

Read more
  • Poniard Pharmaceuticals Abstracts in Professional Journal

  • The Tape's Heartbeat

  • Market looks jumpy for Tuesday - Feb 16 and more.

More in: Opinions

Stay Tuned for Next Alert!

Written byTapeBeat 02 April 2010
E-mail Print
Stay Tuned for the next alert and visit TapeBeat.Com daily to keep up with the latest momentum and trading alerts.

Breaking News

  • Best Deals and Daily Coupons Website

More in: Breaking News

Media

News image

NMT Medical Seems to be Dramatically Oversold after CLOSURE Trial Data (NASDAQ:NMTI)

  • Results of Synergistic Collaboratio

  • More Research into Mannkind's Afrez

  • A Big Bet Placed On Catalyst Pharma

  • Clarity on Linjeta from FDA May Giv

Lastest bloger

Edmund Kaminski Edmund Kaminski
0 post(s)
Jim Boodog Jim Boodog
2 post(s)
ken ken
0 post(s)

Resources

  • 0
  • 1
  • 2
  • 3
prev
next

L&L Energy, Inc. generated EPS Growth of 158.49% for current year – NASDAQ:LLEN

L&L Energy, Inc. (NASDAQ:LLEN) recently ...

Synthesis Energy Systems, Inc. presenting marvelous Yearly & half yearly performance - NAS

Synthesis Energy Systems, Inc. (NASDAQ:S...

Assured Guaranty Ltd. marvelous earnings per share growth at 286.89% for current year – AG

Assured Guaranty Ltd. (NYSE:AGO) recentl...

Seagate Technology PLC having EPS Current Year Growth of 149.04% - NASDAQ:STX

Seagate Technology PLC (NASDAQ:STX) rece...

Bed Bath & Beyond Inc. presenting Positive Distance From SMA20, SMA50 & SMA200 - NASDAQ:BB

Bed Bath & Beyond Inc. (NASDAQ:BBBY) rec...

KB Home Enjoys Business with Optimum Debt to Equity Rate - NYSE:KBH

KB Home (NYSE:KBH) witnessed an unusual ...

Horizon Lines, Inc. traded with an unusual volume but ended in Red - NYSE:HRZ

Horizon Lines, Inc. (NYSE:HRZ) recently ...

A123 Systems, Inc. currently holds strong annual sales growth of 164.69% for past 5 years

A123 Systems, Inc. (NASDAQ:AONE) recentl...

ValueVision Media, Inc. gave performance of 223.40% for six months - NASDAQ:VVTV

ValueVision Media, Inc. (NASDAQ:VVTV) sh...

Altair Nanotechnologies, Inc. even ended in Red but safe from 52 week low of 34.17% - NASD

Altair Nanotechnologies, Inc. (NASDAQ:AL...

SYNNEX Corporation traded with EPS Growth of 31.22% for current year - NYSE:SNX

SYNNEX Corporation (NYSE:SNX) shares wer...

Newcastle Investment Corp. marvelous opertaing & net profit margin for past 12 months - NY

Newcastle Investment Corp. (NYSE:NCT) sh...

Steelcase Inc. after earnings announcement traded with an unusual volume - NYSE:SCS

Steelcase Inc. (NYSE:SCS) shares were tr...

Central Fund of Canada Limited (USA) admirable year over year quarterly earning & revenue

Central Fund of Canada Limited (USA) (AM...

Cell Therapeutics, Inc. current price gone higher from 52 Week low price of 283.33% - NASD

Cell Therapeutics, Inc. (NASDAQ:CTIC) re...

optionsXpress Holdings, Inc. favorable Gross, Operating & Net Profit Margin - NASDAQ:OXPS

optionsXpress Holdings, Inc. (NASDAQ:OXP...

Most Popular

Subscribe to Stock Alerts

Antigenics Oncophage Well Ahead of Dendreon (NASDAQ:AGEN)

Why Linjeta Could Revolutionize Diabetes Care, Biodel (NASDAQ: BIOD)

A Big Bet Placed On Catalyst Pharmaceutical Partners (NASDAQ:CPRX)

Biodel's VIAject May Push Mannkind's Afrezza Aside (BIOD, MNKD)

Show all

Elan Corporation, plc (ADR) EPS Growth f

Tapebeat Staff | Thursday, 7 April 2011

Elan Corporation, plc (ADR) (NYSE:ELN) recently traded higher than its average volume.  ELN was opened at $7.15 increased +0.44 points or +6.15%. ELN transacted shares during the day were over 14.80 million shares however it has an average volume of 3.20 million shares. ELN has a gross margin of 50.13% as compared to operating margin of -16.38% and its profit margin remained -27.76% for the last 12 months. The company has earnings of $-324.70 million and made $1.17 billion revenue for the last 12 month. Its quarter to quarter earnings per share (EPS) remained -14.13%. The company has 586.70 million of outstanding ...

  • Elan Corporation, plc (ADR) EPS Growth for next year hanged about 157.10% - NYSE:ELN

Trading Alerts

  • Superconductor Technologies, Inc. Going to Announce its Earnings on 21st of Feb - NASDAQ:SCON
  • Recommended Website for Penny Stocks
  • Trading Alert for May 10, 2010
  • Stay Tuned for Next Alert!
  • Watchlist for March 15, 2010
  • Watchlist for March 4, 2010

Latest Forum Topics

  • Forum
  • Crosshair Exploration & Mining (AMEX: CXZ )
  • DayStar Technologies, Inc.(NasdaqCM: DSTI )
  • GenVec, Inc. (GNVC)
  • SUPR Superior Bancorp

Market Summary

  • L&L Energy, Inc. generated EPS Growth of 158.49% for current year – NASDAQ:LLEN
  • Synthesis Energy Systems, Inc. presenting marvelous Yearly & half yearly performance - NASDAQ:SYMX
  • Assured Guaranty Ltd. marvelous earnings per share growth at 286.89% for current year – AGO
  • Seagate Technology PLC having EPS Current Year Growth of 149.04% - NASDAQ:STX

Lastest News

  • Best Deals and Daily Coupons Website
  • TapeBeat.com
  • Mission Statement
  • Disclaimer
Tapebeat.com © 2009 By viewing this website you agree to terms of disclaimer